Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dual inhibition of HERs and PD-1 counteract resistance in KRAS ^G12C -mutant head and neck cancer.

Autor: Novoplansky O; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Jagadeeshan S; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Prasad M; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Yegodayev KM; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Marripati D; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Shareb RA; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Greenshpan Y; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Mathukkada S; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Ben-Lulu T; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Bhattacharya B; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Porgador A; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Kong D; School of Pharmaceutical Sciences, Tianjin Medical University, Tianjin, China., Brägelmann J; Department of Translational Genomics, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937, Cologne, Germany.; Mildred Scheel School of Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, 50937, Cologne, Germany., Gutkind JS; Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Elkabets M; The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel. moshee@bgu.ac.il.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. moshee@bgu.ac.il.

Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Nov 20; Vol. 43 (1), pp. 308. Date of Electronic Publication: 2024 Nov 20.